The Dapa-TAVI trial is investigating the efficacy and safety of Dapagliflozin in a broad spectrum of frail patients who underwent TAVI to assess whether the use of Dapagliflozin in this setting may help in reducing the quite significant HF hospitalization risk [ 49 ].
← all excerpts
Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current Literature.
1
—
—